Paragon 28 Inc

NYSE:FNAUnited States

Paragon 28, Inc. is a medical device company. The Company develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products and product families include plates and plating systems, screws, staples, and nails to address all foot and ankle procedures, including fracture fixation, forefoot, or hallux valgus, which includes bunion and hammertoe, ankle, flatfoot, or progressive collapsing foot deformity (PCDF), Charcot foot and Ortho biologics. It provides a comprehensive portfolio of solutions that includes surgical implants and disposables, as well as surgical instrumentation. The Company’s suite of surgical solutions comprises 75 product systems, including approximately 9,200 SKUs, which comprises of approximately 6,800 implants, 1,400 instruments and 1,000 disposable and other SKUs. Its products are available in a variety of sizes and configurations to suit the individual patient’s anatomical and surgical requirements.

Contact Information

Headquarters

14445 Grasslands DriveENGLEWOOD, CO, United States 80112

Phone

720-912-1332

Fax

302-655-5049

Executives

Chairman of the Board, President, Chief Executive Officer

Albert Dacosta

Chief Financial Officer

Stephen Deitsch

Chief Technology Officer

Jason Edie

Chief Accounting Officer, Controller

Erik Mickelson

General Counsel, Secretary

Jonathan Friedman